Nifty

:

13055.15

Sensex

:

44523.02

128.70 (1.00%)
445.87 (1.01%)

Login

Nifty
Sensex

:
:

13055.15
44523.02

128.70 (1.00%)
445.87 (1.01%)

Abbott India Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

70/99

BSE: 500488 | NSE: ABBOTINDIA

Watchlist

NSE BSE

15297.65

24-Nov-2020

Open
High
Low
Previous Close

15205.00
15475.00
15205.00
15197.60

Volume
Traded Value (lacs)
52 Week High
52 Week Low

17108
2628.74
18679.75
12186.55

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

32,523.54
49.03
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

30,326.17
1.63%
14.27

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
9.38
7.46

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
15.76
7.64

PAT CAGR (%)

10 Years
5 Years
3 Years

-
18.36
13.90

P:E (Median)

8 Years
5 Years
3 Years

36.69
38.15
40.23

P:BV (Average)

8 Years
5 Years
3 Years

14.06
14.06
14.06

EV:EBITDA (Average)

8 Years
5 Years
3 Years

21.40
24.41
26.64

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 1,054.85 1,054.80 0.00% 1,064.27 998.89 6.55% 961.20 906.31 6.06% 1,078.25 947.65 13.78%
Expenses 814.14 850.67 -4.29% 830.85 824.71 0.74% 822.77 753.41 9.21% 838.55 801.16 4.67%
EBITDA 240.71 204.13 17.92% 233.42 174.18 34.01% 138.43 152.90 -9.46% 239.70 146.49 63.63%
EBIDTM 22.82% 19.35% 21.93% 17.44% -0.29% 16.87% 22.23% 15.46%
Other Income 22.06 28.90 -23.67% 27.63 29.60 -6.66% 28.13 29.36 -4.19% 27.76 37.63 -26.23%
Interest 4.79 1.82 163.19% 4.45 2.03 119.21% 2.82 0.75 276.00% 1.86 0.43 332.56%
Depreciation 14.29 14.95 -4.41% 14.10 14.80 -4.73% 14.81 4.91 201.63% 15.05 3.96 280.05%
PBT 243.69 216.26 12.68% 242.50 186.95 29.71% 148.93 176.60 -15.67% 250.55 179.73 39.40%
Tax 62.96 37.93 65.99% 62.15 70.01 -11.23% 37.96 63.41 -40.14% 63.86 62.68 1.88%
PAT 180.73 178.33 1.35% 180.35 116.94 54.22% 110.97 113.19 -1.96% 186.69 117.05 59.50%
PATM 17.13% 16.91% 16.95% 11.71% 2.87% 12.49% 17.31% 12.35%
EPS 85.25 84.12 1.34% 85.07 55.16 54.22% 52.34 53.39 -1.97% 88.06 55.21 59.50%

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Dec 12 Dec 11 Dec 10
Net Sales 4,158.57 4,093.14 3,678.60 3,298.50 2,902.56 2,614.50 2,289.33 2,275.90 1,652.69 1,490.21 1,036.87 Net Sales Growth 6.42% 11.27% 11.52% 13.64% 11.02% 14.20% 0.59% 37.71% 10.90% 43.72% Cost Of Goods Sold 2,282.41 2,315.65 2,088.60 1,900.43 1,714.96 1,494.45 1,314.45 1,299.16 974.96 862.72 631.48 Gross Profit 1,876.16 1,777.49 1,590.01 1,398.07 1,187.60 1,120.05 974.87 976.75 677.72 627.49 405.39 GP Margin 45.12% 43.43% 43.22% 42.39% 40.92% 42.84% 42.58% 42.92% 41.01% 42.11% 39.10% Total Expenditure 3,306.31 3,336.96 3,074.56 2,775.10 2,507.75 2,250.77 1,978.01 2,008.62 1,451.27 1,314.83 967.43 Power & Fuel Cost - 13.73 12.61 10.26 7.74 6.98 5.96 9.08 9.06 8.37 6.97 % Of Sales - 0.34% 0.34% 0.31% 0.27% 0.27% 0.26% 0.40% 0.55% 0.56% 0.67% Employee Cost - 476.11 435.58 393.69 345.27 341.09 305.40 299.74 206.20 167.35 108.13 % Of Sales - 11.63% 11.84% 11.94% 11.90% 13.05% 13.34% 13.17% 12.48% 11.23% 10.43% Manufacturing Exp. - 18.33 14.42 11.52 13.14 11.94 11.59 18.29 6.19 4.30 25.36 % Of Sales - 0.45% 0.39% 0.35% 0.45% 0.46% 0.51% 0.80% 0.37% 0.29% 2.45% General & Admin Exp. - 209.71 267.14 239.06 205.33 191.08 152.91 192.05 113.38 111.64 48.33 % Of Sales - 5.12% 7.26% 7.25% 7.07% 7.31% 6.68% 8.44% 6.86% 7.49% 4.66% Selling & Distn. Exp. - 222.06 191.15 156.94 148.33 152.27 135.60 130.83 98.13 116.14 114.92 % Of Sales - 5.43% 5.20% 4.76% 5.11% 5.82% 5.92% 5.75% 5.94% 7.79% 11.08% Miscellaneous Exp. - 81.37 65.05 63.19 72.98 52.96 52.10 59.47 43.34 44.30 114.92 % Of Sales - 1.99% 1.77% 1.92% 2.51% 2.03% 2.28% 2.61% 2.62% 2.97% 3.11% EBITDA 852.26 756.18 604.04 523.40 394.81 363.73 311.32 267.28 201.42 175.38 69.44 EBITDA Margin 20.49% 18.47% 16.42% 15.87% 13.60% 13.91% 13.60% 11.74% 12.19% 11.77% 6.70% Other Income 105.58 114.65 113.98 118.09 60.15 51.24 48.48 49.29 22.70 19.80 35.99 Interest 13.92 8.53 2.25 3.82 2.04 2.52 0.50 0.08 0.02 0.03 0.04 Depreciation 58.25 59.61 16.92 16.19 16.43 14.44 14.94 21.93 19.49 15.00 11.25 PBT 885.67 802.69 698.85 621.48 436.49 398.01 344.36 294.55 204.60 180.16 94.14 Tax 226.93 209.76 248.52 220.26 159.84 142.76 115.40 96.10 70.29 59.77 33.21 Tax Rate 25.62% 26.13% 35.56% 35.44% 36.62% 35.87% 33.51% 32.63% 32.69% 33.18% 35.28% PAT 658.74 592.93 450.33 401.22 276.65 255.25 228.96 198.45 144.70 120.39 60.94 PAT before Minority Interest 658.74 592.93 450.33 401.22 276.65 255.25 228.96 198.45 144.70 120.39 60.94 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 15.84% 14.49% 12.24% 12.16% 9.53% 9.76% 10.00% 8.72% 8.76% 8.08% 5.88% PAT Growth 25.35% 31.67% 12.24% 45.03% 8.38% 11.48% 15.37% 37.15% 20.19% 97.55% EPS 310.73 279.68 212.42 189.25 130.50 120.40 108.00 93.61 68.25 56.79 28.75

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Dec 12 Dec 11 Dec 10
Shareholder's Funds 2,431.71 2,008.59 1,692.76 1,386.94 1,195.60 937.53 787.85 646.86 544.14 305.38 Share Capital 21.25 21.25 21.25 21.25 21.25 21.25 21.25 21.25 21.25 13.68 Total Reserves 2,374.70 1,959.59 1,650.56 1,352.37 1,174.35 916.28 766.60 625.61 522.89 291.71 Non-Current Liabilities 209.60 62.36 40.75 34.84 29.25 432.46 442.99 30.68 230.24 0.19 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 84.84 75.43 55.35 47.22 38.64 438.98 444.27 29.43 236.44 0.00 Current Liabilities 891.10 856.89 668.08 631.64 382.27 834.22 652.31 229.55 238.52 556.48 Trade Payables 657.77 663.52 480.62 474.69 230.14 193.56 136.22 101.35 120.90 57.75 Other Current Liabilities 118.24 89.42 81.80 77.90 86.90 59.35 53.91 44.09 41.28 40.21 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 115.09 103.96 105.66 79.05 65.23 581.31 462.18 84.11 76.35 458.52 Total Liabilities 3,532.41 2,927.84 2,401.59 2,053.42 1,607.12 2,204.21 1,883.15 907.09 1,012.90 862.05 Net Block 269.83 104.96 81.38 109.60 108.46 96.04 98.25 108.67 79.66 49.71 Gross Block 344.84 164.52 124.25 139.69 122.83 215.65 209.23 203.65 191.81 118.21 Accumulated Depreciation 75.01 59.56 42.87 30.10 14.37 119.61 110.98 94.98 112.15 68.50 Non Current Assets 327.77 166.85 136.12 160.41 156.49 540.81 540.48 133.23 326.64 50.57 Capital Work in Progress 1.64 0.73 2.17 6.28 2.83 3.91 1.27 0.51 0.36 0.86 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 50.92 56.69 48.91 41.53 42.47 438.62 438.94 22.88 246.62 0.00 Other Non Current Assets 5.38 4.47 3.66 3.00 2.73 2.24 2.02 1.17 0.00 0.00 Current Assets 3,204.64 2,760.98 2,265.47 1,893.02 1,450.63 1,663.39 1,342.67 773.86 686.26 811.48 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 527.17 606.79 585.33 500.63 370.10 384.13 359.05 263.63 254.90 128.59 Sundry Debtors 317.91 276.11 263.44 176.22 145.02 129.15 109.18 141.03 132.61 65.28 Cash & Bank 2,197.37 1,684.28 1,031.35 1,090.92 839.42 643.89 462.84 323.34 258.95 188.51 Other Current Assets 162.18 100.56 95.80 19.01 96.08 506.22 411.61 45.85 39.80 429.10 Short Term Loans & Adv. 105.79 93.24 289.55 106.23 79.51 488.68 397.22 41.15 33.69 427.90 Net Current Assets 2,313.54 1,904.09 1,597.39 1,261.38 1,068.36 829.17 690.36 544.31 447.74 255.00 Total Assets 3,532.41 2,927.83 2,401.59 2,053.43 1,607.12 2,204.20 1,883.15 907.09 1,012.90 862.05

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Dec 12 Dec 11 Dec 10
Cash From Operating Activity 626.11 499.13 152.70 307.22 248.68 214.78 155.31 101.35 24.07 46.06 PBT 802.69 698.85 621.48 436.49 398.01 344.36 294.55 214.99 180.16 94.14 Adjustment -17.23 -77.46 -76.92 -37.02 -23.98 -37.19 -1.08 -9.23 1.40 6.57 Changes in Working Capital 69.82 134.41 -186.96 66.52 21.85 23.48 -28.45 -39.78 -97.28 -5.61 Cash after chg. in Working capital 855.28 755.80 357.61 466.00 395.87 330.65 265.03 165.98 84.28 95.10 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -229.17 -256.67 -204.90 -158.78 -147.20 -115.87 -109.71 -64.63 -60.21 -49.04 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -401.19 -257.00 -214.84 -155.41 -77.19 -186.72 -143.90 -58.51 5.05 -15.75 Net Fixed Assets -181.23 -38.83 19.55 -20.31 93.90 -9.06 -6.34 -11.99 -73.10 -11.61 Net Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others -219.96 -218.17 -234.39 -135.10 -171.09 -177.66 -137.56 -46.52 78.15 -4.14 Cash from Financing Activity -216.79 -142.80 -102.43 -89.76 -80.29 -57.58 -42.35 -42.01 -42.02 -27.24 Net Cash Inflow / Outflow 8.13 99.33 -164.56 62.05 91.19 -29.52 -30.94 0.83 -12.90 3.08 Opening Cash & Equivalents 137.01 37.68 202.24 140.19 49.00 78.52 109.46 108.63 70.38 69.21 Closing Cash & Equivalent 145.14 137.01 37.68 202.24 140.19 49.00 78.52 109.46 108.63 72.29

Financial Ratios

Standalone

Right to Left

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Dec 12 Dec 11 Dec 10
Book Value (Rs.) 1127.54 932.19 786.76 646.43 562.65 441.20 370.77 304.41 256.08 223.31 ROA 18.36% 16.90% 18.01% 15.12% 13.39% 11.20% 14.22% 15.07% 12.84% 7.56% ROE 27.09% 24.66% 26.35% 21.54% 23.93% 26.54% 27.66% 24.30% 28.34% 21.12% ROCE 36.54% 37.88% 40.61% 33.96% 37.55% 39.98% 41.07% 36.11% 42.42% 32.65% Fixed Asset Turnover 16.07 25.48 25.06 22.39 15.63 10.91 11.19 8.47 9.73 9.26 Receivable days 26.49 26.77 24.26 19.95 18.91 18.77 19.78 29.82 23.94 19.19 Inventory Days 50.56 59.14 59.93 54.07 52.03 58.54 49.21 56.51 46.40 40.41 Payable days 78.62 76.56 66.93 54.71 38.57 32.92 23.41 31.17 26.13 19.87 Cash Conversion Cycle -1.57 9.35 17.26 19.31 32.37 44.39 45.58 55.17 44.21 39.74 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Interest Cover 95.08 311.82 163.60 215.33 158.63 685.07 3532.82 8996.52 6006.28 2433.69

Top Investors:

l and t mutual fund trustee ltd-l and t mid cap fund

Annual Reports:

News Update:

Abbott gets nod from DCGI for once-a-day formulation ‘Ivabradine’
3rd Sep 2020, 14:03 PM

The company plans to launch Ivabradine prolonged release tablets in the Indian market in the coming weeks
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback